'For the quarter ending March 2023, consolidated Net sales (including other operating income) of Max Healthcare Institute has increased 29.60% to Rs 1214.51 crore compared to quarter ended Mar 2022.  Operating profit margin has jumped from 22.26% to 28.02%, leading to 63.19% rise in operating profit to Rs 340.34 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 20.92% to 20.73%.   Employee cost decreased from 18.16% to 17.18%.   Other expenses fell from 38.55% to 34.23%.   Consultancy Management service cost fell from 23.48% to 21.45%.   

Other income rose 52.23% to Rs 40.22 crore.  PBIDT rose 61.96% to Rs 380.56 crore.  Provision for interest fell 11.83% to Rs 19.53 crore.  Loan funds declined from Rs 913.38 crore as of 31 March 2022 to Rs 688.96 crore as of 31 March 2023.  Inventories rose to Rs 76.23 crore as of 31 March 2023 from ...

• 

  (28-Feb-2026)

  Vesuvius India

  Net jumps 33% on higher OI
• 

  (26-Feb-2026)

  Foseco India

  Net down 35% on higher EO Exp
• 

  (26-Feb-2026)

  KSB

  Net up 11%, sales up 8%
• 

  (26-Feb-2026)

  Sanofi India

  OP down 23.67%